Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (Europe)

PHASE4CompletedINTERVENTIONAL
Enrollment

388

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

February 29, 2004

Conditions
Osteoarthritis, Knee
Interventions
DRUG

Ibuprofen

800 mg oral tablet 3 times daily with meals for 6 weeks

DRUG

Placebo

Matched placebo orally for 6 weeks

DRUG

Celecoxib

200 mg oral capsule once daily with morning meal for 6 weeks

Trial Locations (33)

10435

Pfizer Investigational Site, Berlin

10559

Pfizer Investigational Site, Berlin

11009

Pfizer Investigational Site, Cadiz

12687

Pfizer Investigational Site, Berlin

13125

Pfizer Investigational Site, Berlin

19002

Pfizer Investigational Site, Guadalajara

19057

Pfizer Investigational Site, Schwerin

21255

Pfizer Investigational Site, Tostedt

21680

Pfizer Investigational Site, Stade

24351

Pfizer Investigational Site, Ostseebad Damp

26826

Pfizer Investigational Site, Weener

28035

Pfizer Investigational Site, Madrid

28040

Pfizer Investigational Site, Madrid

28046

Pfizer Investigational Site, Madrid

31848

Pfizer Investigational Site, Bad Münder am Deister

33006

Pfizer Investigational Site, Oviedo

41014

Pfizer Investigational Site, Seville

46009

Pfizer Investigational Site, Valencia

59269

Pfizer Investigational Site, Beckum

08029

Pfizer Investigational Site, Barcelona

08036

Pfizer Investigational Site, Barcelona

B37 7TR

Pfizer Investigational Site, Chelmsly WOOD

TR1 3LJ

Pfizer Investigational Site, Truro

PR7 1NY

Pfizer Investigational Site, Chorley

L1 9AD

Pfizer Investigational Site, Liverpool

WS11 2XY

Pfizer Investigational Site, Cannock

KT15 2BH

Pfizer Investigational Site, Addlestone

HD3 3EA

Pfizer Investigational Site, Huddersfield

NW3 2PF

Pfizer Investigational Site, London

SE5 9RS

Pfizer Investigational Site, London

M41 5SL

Pfizer Investigational Site, Manchester

NE7 7DN

Pfizer Investigational Site, Newcastle upon Tyne

WN6 9EW

Pfizer Investigational Site, Wigan

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00630929 - Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (Europe) | Biotech Hunter | Biotech Hunter